...
首页> 外文期刊>Circulation journal >Is Catheter Ablation a Mature Fruit for Treatment of Atrial Fibrillation? – Is Catheter Ablation Established as a Treatment Option of Atrial Fibrillation? (Con) –
【24h】

Is Catheter Ablation a Mature Fruit for Treatment of Atrial Fibrillation? – Is Catheter Ablation Established as a Treatment Option of Atrial Fibrillation? (Con) –

机译:导管消融术是治疗房颤的成熟果实吗? –是否建立消融导管作为房颤的治疗选择? (骗局)–

获取原文
           

摘要

In recent years, catheter ablation for atrial fibrillation (AF) has evolved in tandem with the results from many large-scale randomized clinical studies with antiarrhythmic drugs. The current situations seem to be a concerted move from pharmacological to non-pharmacological treatment. However, the clinical studies with medications have revealed an important viewpoint for the management of AF: the importance of the core aim of AF treatment and the position of electrographic findings as a surrogate marker. Catheter ablation is under challenge as the answers to these issues are awaited. Moreover, many problems with this invasive therapy are to be solved, most of them deriving from the vague definition of success of ablation and no standardization of the technique. For these reasons, catheter ablation is still on the way to maturation and multicenter studies in Japan are required to set a fair benchmark for Japanese patients, drawing a lesson from randomized clinical studies with medications.??( Circ J ?2010; 74: 1978?-?1982)
机译:近年来,心房纤颤(AF)的导管消融已与许多抗心律不齐药物大规模随机临床研究的结果相结合。当前的情况似乎是从药理学转向非药理学治疗的一致行动。然而,药物的临床研究揭示了房颤治疗的重要观点:房颤治疗的核心目标的重要性以及电子照相结果作为替代标志物的位置。导管消融正面临挑战,因为这些问题的答案正在等待中。此外,这种侵入性疗法的许多问题有待解决,其中大多数是由于消融成功的模糊定义以及该技术的标准化所致。由于这些原因,导管消融仍在走向成熟,在日本需要进行多中心研究以为日本患者树立一个公平的基准,从药物的随机临床研究中吸取教训。(Circ J,2010; 74:1978) ?-?1982)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号